AstraZeneca's Faslodex Drug Not Good Use Of Resources - NICE | FoxBusiness.com
Links shared publicly online about this topic.
- 52total visits
AstraZeneca's Faslodex Drug Not Good Use Of Resources - NICE | FoxBusiness.com
View full resource at foxbusiness.com
Tags: Cancer, Cancer Medication, Breast Cancer, Breast Cancer Medication, Drug, Women's Health, AstraZeneca
Most Recently Shared on August 23, 2011 at 12:26 pm By:
Another cancer-drug rejection for NICE: Watchdog says AstraZeneca's Faslodex doesn't beat current therapy. http://t.co/hwLRiGv $AZN
AstraZeneca seeks a remedy for its patent pain - Telegraph
telegraph.co.uk — “AstraZeneca seeks a remedy for its patent pain - Telegraph” View full resource at telegraph.co.uk
Most Recently Shared on April 21, 2012 at 11:35 pm By:
blogaceutics Pharma and Health Communicator
AstraZeneca seeks a remedy for its patent pain - Telegraph http://t.co/Ju0xunS1
EU agency endorses Bristol, Astra diabetes drug | Reuters
reuters.com — “LONDON (Reuters) - European regulators on Friday backed approval of a new diabetes drug from AstraZeneca and Bristol-Myers Squibb that was rejected last year in the United States.Dapagliflozin belongs” View full resource at reuters.com
Most Recently Shared on April 20, 2012 at 2:07 pm By:
EU agency endorses Bristol, Astra diabetes drug: LONDON (Reuters) - European regulators on Friday backed approva... http://t.co/EeIYYqhz
EU agency endorses Bristol, Astra diabetes drug | Reuters
in.reuters.com — “LONDON (Reuters) - European regulators on Friday backed approval of a new diabetes drug from AstraZeneca and Bristol-Myers Squibb that was rejected last year in the United States.Dapagliflozin belongs” View full resource at in.reuters.com
Most Recently Shared on April 20, 2012 at 2:01 pm By:
EU agency endorses Bristol, Astra diabetes drug http://t.co/nNNLGw4j
International Journal of Emergency Medicine | Abstract | A Randomized Open-Label Trial On The Use Of Budesonide/Formoterol (Symbicort(R)) As An Alternative Reliever Medication For Mild To Moderate Asthmatic Attacks
intjem.com — “Conventionally, a nebulized short acting beta-2 agonist like salbutamol is often used as the reliever in acute exacerbations of asthma. However, recent worldwide respiratory outbreaks discourage routine use of nebulization. Previous studies show that combined budesonide/formoterol (Symbicort(R), AstraZeneca) is effective as both a maintenance and reliever anti-asthmatic medication. Methods: We performed a randomized, open label study from March until August 2011 to compare the bronchodilatory ef” View full resource at intjem.com
Most Recently Shared on April 13, 2012 at 2:00 pm By:
IJEM Emergency Medicine and Medical Journal
A Randomized Open-Label Trial On The Use Of Budesonide/Formoterol (Symbicort(R)) #emergencymedicine #openaccess... http://t.co/PRlUHWdR
AstraZeneca - AstraZeneca and Liverpool School of Tropical Medicine combine resources in the fight against Neglected Tropical Diseases
astrazeneca.com — “AstraZeneca - AstraZeneca and Liverpool School of Tropical Medicine combine resources in the fight against Neglected Tropical Diseases” View full resource at astrazeneca.com
Most Recently Shared on April 12, 2012 at 2:12 pm By:
AZ & Liverpool School of #TropicalMedicine combine resources in fight against #NTDs http://t.co/l2wF6Zmm
Manos Perros talks about AZ's Neglected Tropical Disease strategy - YouTube
youtube.com — “An insight into AstraZeneca's strategy and focus for Neglected Tropical Diseases from Manos Perros, Head of Infection iMed.” View full resource at youtube.com
Most Recently Shared on April 12, 2012 at 1:08 pm By:
Watch: Manos Perros talk about AZ strategy on #NTDs & importance of collaboration http://t.co/hCkxoKSE
Launch of Depaul UK & AstraZeneca report "Making it matter: improving the health of young homeless people"
depauluk.org — “Launch of Depaul UK & AstraZeneca report "Making it matter: improving the health of young homeless people"” View full resource at depauluk.org
Most Recently Shared on April 12, 2012 at 12:06 pm By:
RT @depauluk: Let your MP know they're invited to the launch of our new report with @AstraZeneca http://t.co/NOoy45Nm #makingitmatter
AstraZeneca - AstraZeneca and DNDi to Collaborate on Drug Screening for Neglected Tropical Diseases
astrazeneca.com — “AstraZeneca - AstraZeneca and DNDi to Collaborate on Drug Screening for Neglected Tropical Diseases” View full resource at astrazeneca.com
Most Recently Shared on April 12, 2012 at 11:11 am By:
AZ & @DNDi_HQ to Collaborate on Drug Screening for 3 Neglected Tropical Diseases #NTDs http://t.co/7XMrIZB5
AstraZeneca scouts new drug deals to silence a chorus of critics - FierceBiotech
fiercebiotech.com — “AstraZeneca scouts new drug deals to silence a chorus of critics - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on April 4, 2012 at 12:24 pm By:
John Carroll Health Communicator
AstraZeneca scouts new drug deals to silence a chorus of critics. #biotech http://t.co/6KVAMjSB
INTERVIEW: AstraZeneca R&D Head Predicts More Collaborative Deals - WSJ.com
online.wsj.com — “INTERVIEW: AstraZeneca R&D Head Predicts More Collaborative Deals - WSJ.com” View full resource at online.wsj.com
Most Recently Shared on April 4, 2012 at 12:18 pm By:
reading @stenstovall on AZ #collaboration with @amgen http://t.co/8qssjUoW
Amgen, Astra to collaborate on several drugs | Reuters
in.reuters.com — “(Reuters) - Amgen Inc and British drugmaker AstraZeneca Plc announced on Monday a major collaboration deal to jointly develop and sell five biotech drugs currently in Amgen's developmental pipeline.Under” View full resource at in.reuters.com
Most Recently Shared on April 4, 2012 at 1:34 am By:
James Underberg Doctor, Internist, and Physician
@pharmaguapa Amgen, Astra to collaborate on several drugs but NOT ? AMG 145 (PCSKC Inhibitor?) Curious wedding! http://t.co/p5gX3GZL
AstraZeneca hunting more deals like Amgen tie-up - Courant.com
courant.com — “LONDON (Reuters) - AstraZeneca is seeking more deals to fill its sparse drug pipeline like the one just signed with Amgen , but is not in the market for the kind of large acquisition some investors have speculated about.” View full resource at courant.com
Most Recently Shared on April 3, 2012 at 5:18 pm By:
John Carroll Health Communicator
AstraZeneca talks acquisitions, deals with @ReutersBenHir http://t.co/T5qAFgpJ?
AstraZeneca investors encouraged by partnership with US group Amgen, but FTSE slips back | Business | guardian.co.uk
guardian.co.uk — “Astra and Amgen to collaborate on five biotech drugs, with Astra paying $50m upfront” View full resource at guardian.co.uk
Most Recently Shared on April 3, 2012 at 12:49 pm By:
A roundup of analyst comments on AstraZeneca-Amgen collaboration, from the Guardian http://t.co/bejxWNCX #pharma $AZN $AMGN
AstraZeneca's Susan Galbraith on the current focus areas in cancer treatment - YouTube
youtube.com — “AstraZeneca's Susan Galbraith, Head of Oncology Innovative Medicines Unit, talks about the current focus areas in cancer treatment and the importance of coll...” View full resource at youtube.com
Most Recently Shared on April 3, 2012 at 10:53 am By:
Head of Oncology Susan Galbraith iMed Unit at #AACR describing how AZ is tackling #cancer http://t.co/hJAqo4g7
Amgen, AstraZeneca to Work on Inflammation Drugs - WSJ.com
online.wsj.com — “Amgen and AstraZeneca reached a deal to jointly develop and commercialize five inflammatory disease treatments in Amgen's portfolio.” View full resource at online.wsj.com
Most Recently Shared on April 2, 2012 at 9:36 pm By:
Amgen, AstraZeneca to Work on Inflammation Drugs http://t.co/KHcCwwAf
Advertisement
